Where history meets the present and the future
https://www.historiskamuseet.lu.se/english - 2026-04-29
Filetype
https://www.historiskamuseet.lu.se/english - 2026-04-29
Stina did her PhD between the years 2015 and 2020, focusing on ambient measurements of anthropogenic aerosols, with particular emphasis on organic carbon and soot particles and emissions from the shipping industry. In addition to her primary project, she contributed to two other projects, one looking at soot particles from car traffic and their aging, and another examining soot emissions in Pola
https://www.cec.lu.se/stina-ausmeel-0 - 2026-04-29
PowerPoint-presentation Header – Optional Introduction – should be maximum three lines. Olo que liciumque porem harum hiliquidis ium quo doloreped qui aperum doluptia perumen ditatestia qui volupta spedipsusam, te plab ipiet voluptusamus alibus ent lit aut qui aut placienem es aliberum sum ea aut harum sit apiciat invenda. Date: 2nd of October 2019 Time: 13.00–15.30 Place: Hörsalen, Pufendorfinsti
https://www.cec.lu.se/sites/cec.lu.se/files/affischmall_a3_cec_2019_eng.pptx - 2026-05-01
Museum Stobaeanum Explore the collections of Museum Stobaeanum – the first public museum in Lund, established in the early 18th century, with roots in the cabinet of curiosities of Kilian Stobaeus (1690–1742), professor in natural philosophy and history at Lund University. Who was Kilian Stobaeus? He was a physician, a scientist, and a university vice-chancellor. Kilian Stobaeus was the man whose
https://www.historiskamuseet.lu.se/stobaeus - 2026-04-29
Background: Malaria kills almost 1 million people every year, but the mechanisms behind protective immunity against the disease are still largely unknown. Methodology/Principal Findings: In this study, surface plasmon resonance technology was used to evaluate the affinity (measured as kd) of naturally acquired antibodies to the Plasmodium falciparum antigens MSP2 and AMA1. Antibodies in serum samp
OBJECTIVE: To study long-term work disability before and after tumour necrosis factor (TNF)-antagonist therapy in patients with psoriatic arthritis (PsA). METHODS: Using the population-based South Swedish Arthritis Treatment Group Register, we identified 191 patients with PsA (median age 43 years, range 18-58 years, 54% men), who between January 2003 and December 2007 started treatment with adalim